KRT88P and coinfection: Compared with participants who were positive for anti-HCV alone (group 2), those with HBV/HCV co-infection (group 1) had a lower anti-HBc S/CO ratio (P < 0.001), but sex, age, number of injections, and time from first injection were similar in both groups.